Baltimore, MD, United States of America

Basile Michelet

This inventor holds 1 USPTO granted patent. Top assignee: Cranius LLC. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Basile Michelet. Retrieved from https://idiyas.com/inventor/basile-michelet

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 1.0


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Basile Michelet and Cranial Drug Delivery

Introduction

Basile Michelet is an inventor associated with Baltimore, Maryland, and Cranius LLC. His work includes a patent for a cranial drug delivery system that combines reconstructive implant design with controlled fluid delivery.

Latest Patents

Michelet is credited with 1 patent, titled “Cranial Drug Delivery System.” The patent describes a medical implant housing that can replace missing bone and/or soft tissue while delivering fluid to a target site. Its proposed components include a two-phase propellant, a pump designed to maintain constant infusion pressure, a mechanical flow regulator intended to maintain a constant flow rate, and at least one catheter for delivering the fluid.

Career Highlights

Michelet’s patent focuses on integrating drug-delivery functions into a reconstructive medical implant. The described system brings together implant housing, pressure management, flow regulation, and catheter-based delivery.

Collaborations

Michelet is associated with Cranius LLC. Owen Friesen and Josiah Verkaik are identified as his coworkers.

Conclusion

Basile Michelet’s patented cranial drug delivery system combines reconstructive implant technology with mechanisms designed to regulate medication delivery.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…